Latest News
Protecting Standards of Care for Teplizumab Infusions in Type 1 Diabetes A unified statement from U.S. pediatric endocrinology leaders
This statement was authored by a group of U.S. pediatric endocrinology leaders with the greatest collective clinical and translational experience administering teplizumab and leading immunotherapy…
Featured Resources
If you were not able to participate in the Board Review Course in person, no worries, you can now purchase access to the all the course materials:
-
- Access to video files that capture the audio recordings of lectures, synchronized to the images of the slides presented.
-
- Full color pdf of all slides plus and any supplemental information from speakers that was not covered during the presentation.
You can watch the videos on your own time - and as many times as you need.

